血管內皮生長因子165(VEGF165)單克隆抗體
Monoclonal Antibody to Vascular Endothelial Growth Factor 165 (VEGF165)
- 編號MAB696Hu23
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)A12
- Ig亞型 IgG
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原RPB696Hu01-血管內皮生長因子165(VEGF165)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠)
- 應用WB; IHC; FCM
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 774¥ 1806¥ 2580¥ 6450¥ 25800
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
DAB staining on IHC-P; Sample: Human Kidney Tissue; Primary Ab: 10μg/ml Mouse Anti-Human VEGF165 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
DAB staining on IHC-P;
Sample: Human Mammary gland Tissue;
Primary Ab: 10μg/ml Mouse Anti-Human VEGF165 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
DAB staining on IHC-P;
Sample: Human Liver cancer Tissue;
Primary Ab: 10μg/ml Mouse Anti-Human VEGF165 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
Western Blot; Sample: Lane1: Rat Cerebrum lysate; Lane3: Rat Cerebellum lysate Primary Ab: 5μg/ml Mouse Anti-Human VEGF165 Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
Human Hela cell line was stained with 10μg/ml mouse Anti-human VEGF165 Monoclonal Antibody (Catalog MAB696Hu23, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對VEGF165的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別VEGF165。
用法
Western blotting: 0.5-5μg/mL
Immunohistochemistry: 5-50μg/mL
Immunocytochemistry: 5-50μg/mL
Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| APB696Hu61 | 血管內皮生長因子165(VEGF165)活性蛋白 | Cell?culture;?Activity?Assays. |
| APB696Hu01 | 血管內皮生長因子165(VEGF165)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPB696Hu01 | 血管內皮生長因子165(VEGF165)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPB696Hu61 | 血管內皮生長因子165(VEGF165)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB696Hu01 | 血管內皮生長因子165(VEGF165)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB696Hu21 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB; IHC |
| MAB696Hu22 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB; IHC |
| MAB696Hu25 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB696Hu24 | 血管內皮生長因子165(VEGF165)單克隆抗體 | IHC |
| MAB696Hu23 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB; IHC; FCM |
| MAB696Hu26 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB |
| MAB696Hu27 | 血管內皮生長因子165(VEGF165)單克隆抗體 | IHC |
| MAB696Hu29 | 血管內皮生長因子165(VEGF165)單克隆抗體 | IHC |
| FAB696Hu08 | 抗血管內皮生長因子165(VEGF165)單克隆抗體 | Flow cytometry. |
| FAB696Hu06 | 抗血管內皮生長因子165(VEGF165)單克隆抗體 | Flow cytometry. |
| FAB696Hu02 | 抗血管內皮生長因子165(VEGF165)單克隆抗體 | Flow cytometry. |
| FAB696Hu04 | 抗血管內皮生長因子165(VEGF165)單克隆抗體 | Flow cytometry. |
| SEB696Hu | 血管內皮生長因子165(VEGF165)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB696Hu | 血管內皮生長因子165(VEGF165)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Oncotarget | Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells.[pubmed:29100316] |
| Tissue Eng Regen Med | Osteogenic and Angiogenic Potency of VEGF165-Transfected Canine Bone Marrow Mesenchymal Cells Combined with Coral Hydroxyapatite in Vitro[34302695] |